Understanding factors affecting prostate cancer progression
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NA · Centre Hospitalier Universitaire de la Guadeloupe · NCT06046131
This study is trying to find out what factors affect how prostate cancer grows in different people to help improve treatment and prevention for those at higher risk.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 3000 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Centre Hospitalier Universitaire de la Guadeloupe (other) |
| Locations | 2 sites (Rennes, Ille-et-Vilaine and 1 other locations) |
| Trial ID | NCT06046131 on ClinicalTrials.gov |
What this trial studies
This project aims to identify the clinical, genetic, and environmental factors that influence the progression of prostate cancer. By building two prospective cohorts in Guadeloupe and Rennes, the study will collect data through structured questionnaires and biological samples from patients diagnosed with prostate cancer. The goal is to understand why some cases are indolent while others are aggressive, taking into account the patients' ethno-geographic backgrounds and various risk factors. This knowledge could help tailor treatment and prevention strategies for high-risk populations.
Who should consider this trial
Good fit: Ideal candidates include adult patients with newly diagnosed prostate cancer residing in Guadeloupe, Martinique, or Brittany.
Not a fit: Patients with physical or mental health conditions that prevent participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized treatment options and improved prevention strategies for prostate cancer.
How similar studies have performed: While there have been studies on prostate cancer progression, this approach focusing on ethno-geographic determinants is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Inclusion criteria: Adult patients with incident case of prostate cancer Patient consulting the University Hospital of Guadeloupe or the University Hospital of Rennes Patient who resides in the departments of Guadeloupe or Martinique or the community of Saint-Martin or in Britany Patient affiliated or beneficiary of the social security signed consent Exclusion Criteria: Physical or mental health judjed by the investigator as precluding participation in the research Protected adults (guardianship, curatorship, safeguard of justice).
Where this trial is running
Rennes, Ille-et-Vilaine and 1 other locations
- CHU of Rennes — Rennes, Ille-et-Vilaine, France (NOT_YET_RECRUITING)
- CHU of Guadeloupe — Pointe-à-Pitre, Guadeloupe, Guadeloupe (RECRUITING)
Study contacts
- Study coordinator: Valérie HAMONY-SOTER
- Email: valerie.soter@chu-guadeloupe.fr
- Phone: +590 590 93 46 77
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Prostatic Neoplasm, Adenocarcinoma, Neoplasm Recurrence, Neoplasm Metastasis